Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy

Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy

BackgroundThis study aimed to develop and validate a novel nomogram to predict survival in advanced non-small cell lung cancer (NSCLC) receiving programmed cell death 1 (PD-1) inhibitor plus chemotherapy with or without antiangiogenic therapy.MethodsA total of 271 patients with advanced NSCLC who re...

Full description

Bibliographic Details
Main Authors: Yahua Wu, Chengliu Lv, Mingqian Lin, Yaping Hong, Bin Du, Na Yao, Yingjiao Zhu, Xiaohui Ji, Jiancheng Li, Jinhuo Lai
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Immunology
Subjects:
advanced NSCLC
anti-PD-1
combined therapy
nomogram
survival
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1297188/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1297188/full

Similar Items